Package 68001-665-04

Brand: dasatinib

Generic: dasatinib
NDC Package

Package Facts

Identity

Package NDC 68001-665-04
Digits Only 6800166504
Product NDC 68001-665
Description

30 TABLET, FILM COATED in 1 BOTTLE (68001-665-04)

Marketing

Marketing Status
Marketed Since 2025-09-29
Brand dasatinib
Generic dasatinib
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3ff0e7fd-3f99-fbdd-e063-6294a90a24c7", "openfda": {"upc": ["0368001662062", "0368001661065", "0368001665049", "0368001663045", "0368001664042"], "unii": ["RBZ1571X5H"], "rxcui": ["643105", "643107", "643109", "799047", "1045402", "1045406"], "spl_set_id": ["02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (68001-665-04)", "package_ndc": "68001-665-04", "marketing_start_date": "20250929"}], "brand_name": "Dasatinib", "product_id": "68001-665_3ff0e7fd-3f99-fbdd-e063-6294a90a24c7", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "68001-665", "generic_name": "dasatinib", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dasatinib", "active_ingredients": [{"name": "DASATINIB", "strength": "140 mg/1"}], "application_number": "ANDA217217", "marketing_category": "ANDA", "marketing_start_date": "20250929", "listing_expiration_date": "20261231"}